Compare IDYA & LPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IDYA | LPL |
|---|---|---|
| Founded | 2015 | 1985 |
| Country | United States | South Korea |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 3.6B |
| IPO Year | 2019 | 2004 |
| Metric | IDYA | LPL |
|---|---|---|
| Price | $35.87 | $3.37 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 16 | 1 |
| Target Price | ★ $52.86 | N/A |
| AVG Volume (30 Days) | 1.4M | ★ 3.1M |
| Earning Date | 05-06-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 61.90 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $218,710,000.00 | N/A |
| Revenue This Year | N/A | $1.35 |
| Revenue Next Year | $201.05 | $2.94 |
| P/E Ratio | ★ N/A | $25.64 |
| Revenue Growth | ★ 3024.43 | N/A |
| 52 Week Low | $21.33 | $3.34 |
| 52 Week High | $40.58 | $5.83 |
| Indicator | IDYA | LPL |
|---|---|---|
| Relative Strength Index (RSI) | 50.34 | 31.57 |
| Support Level | $32.85 | N/A |
| Resistance Level | $38.17 | $4.37 |
| Average True Range (ATR) | 1.45 | 0.13 |
| MACD | -0.47 | -0.02 |
| Stochastic Oscillator | 4.70 | 1.40 |
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275 (Werner Helicase), IDE161 (PARG), and IDE705 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.
LG Display Co Ltd manufacture TFT-LCD and OLED technology-based display panels in a broad range of sizes and specifications mainly for use in IT products (comprising notebook computers, desktop monitors and tablet computers), televisions, mobile devices, including smartphones, as well as auto products, and it are one of the world's suppliers of large-sized OLED television panels. It also manufacture display panels for industrial and other applications, including entertainment systems and medical diagnostic equipment.